Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $2.03B.
ENTERPRISE VALUE (EV)
$2.03B
UroGen Pharma Ltd.
Market Cap
$2.02B
Enterprise Value (EV)
$2.03B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| UroGen Pharma Ltd. (URGN) | $2.02B | $2.03B |
| Aurinia Pharmaceuticals Inc. (AUPH)vs › | $2.02B | $1.90B |
| BioCryst Pharmaceuticals, Inc. (BCRX)vs › | $2.02B | $2.28B |
| Progyny, Inc. (PGNY)vs › | $2.03B | $1.90B |
| Vericel Corporation (VCEL)vs › | $2.05B | $2.02B |
| Fortrea Holdings Inc. (FTRE)vs › | $1.98B | $2.93B |
| Celldex Therapeutics, Inc. (CLDX)vs › | $2.06B | $2.02B |
| Viridian Therapeutics, Inc. (VRDN)vs › | $2.06B | $2.14B |
| Inspire Medical Systems, Inc. (INSP)vs › | $1.97B | $1.87B |
| Alvotech (ALVO)vs › | $2.08B | $3.39B |
Market Cap
$2.02B
Total Debt
$122.21M
Cash
$110.75M
Enterprise Value
$2.03B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
